Protocolized oxytocin infusion for elective cesarean delivery: a retrospective before-and-after study

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Pharmacology

Background:

• Oxytocin is crucial for preventing postpartum hemorrhage (PPH) after cesarean delivery.
• Current methods involve manual adjustment of oxytocin infusion, leading to variable dosing.
• A novel oxytocin protocol using a syringe pump with stratified dosing was developed to optimize administration.

Purpose of the Study:

• To compare the clinical impact of a novel oxytocin protocol (syringe pump, stratified dose) versus conventional oxytocin administration (infusion bag).
• To evaluate differences in total oxytocin dosage, blood loss, and adverse events within 24 hours postpartum.

Main Methods:

• Retrospective cohort study of 262 patients undergoing elective cesarean delivery under neuraxial anesthesia.
• Control group: conventional oxytocin infusion (5-10 units in bag, manual adjustment).
• Protocol group: stratified oxytocin bolus (1 or 3 units) followed by infusion (5 or 10 units/hr) via syringe pump based on PPH risk.

Main Results:

• The novel oxytocin protocol group showed significantly lower intraoperative (9.7 vs. 11.7 units) and postoperative (15.9 vs. 18 units) oxytocin requirements.
• Reduced oxytocin use was more pronounced in patients with low PPH risk.
• No significant differences were observed in estimated blood loss, need for additional uterotonics, or other adverse events between groups.

Conclusions:

• The novel oxytocin infusion protocol effectively reduces oxytocin requirements in elective cesarean deliveries under neuraxial anesthesia.
• This protocol does not increase postpartum blood loss or adverse clinical events.
• Further research may be needed to identify additional clinical benefits of the novel protocol.